TrialClinical drug investigation2012

First-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer : analysis of the Italian patients enrolled in the SAiL study.

Alessandra Bearz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.